Brain Scientific Inc. (BRSF) is Making EEGs Accessible to 5,900 US Hospitals
- 5,900 hospitals in the US lack the necessary extensive EEG tech
- BRSF has created a cost-effective solution capable of supplying these hospitals with the equipment needed and broadening the reach of each neurologist
- Emergency departments and hospitals are not the only markets in need of brain monitoring devices, and the industry is expected to grow to $208 billion by 2023
For most U.S. patients, an EEG is mostly unavailable during their journey, from home by EMS to the Emergency department. Additionally, for those patients who are admitted to the ICU, less than 45 percent of ICUs offer EEG monitoring. There are approximately 6,090 hospitals in the U.S., and around 5,900 of them lack the necessary extensive EEG tech coverage. There are several reasons for the lack of access:
- Costs and/or space: 70% of US hospitals do not have the equipment for routine EEGs
- Traditional EEGs require a specialized technician to administer and read the data
- The equipment is bulky, which restricts accessibility and mobility
- Twenty (20) states have less than 10 neurologists per 10,000 patients
- Neurological care needs are increasing with the aging population
Brain Scientific (OTCQB: BRSF) has created a solution that makes EEG technology accessible. The Company’s neurotech ecosystem is making it possible for all hospitals to perform EEG tests efficiently. The technology is simple to use. Neurologists are given the resources necessary to automate the tedious tasks and focus their energy on the patient while simultaneously broadening their range of impact.
BRSF’s ecosystem begins with the disposable and easy-to-apply clinical-grade NeuroCap(TM), patented and FDA-cleared, that comes in small, medium, large, and pediatric (extra small) sizes. This disposable headset comes equipped with 22 pre-gelled electrodes that eliminate the task of head measurement and electrode placement. This significantly reduces the amount of time needed to set up, limiting the amount of contact between the patient and the medical professional applying the headset. In addition, because it is disposable and does not need to be painstakingly cleaned before moving on to the next patient, more EEGs can be administered, and the risk of cross-infection is significantly reduced.
The NeuroEEG(TM), patented and FDA cleared, is a portable and wireless EEG amplifier that fits into the palm of your hand and is used to monitor electrical brain activity.
By making EEG technology more available, BRSF has created a time-saving and cost-effective solution for hospitals while simultaneously meeting the growing need for additional neurological care of the communities those hospitals serve.
Emergency departments and hospitals are not the only markets that require brain monitoring devices. Improved technology is necessary in specialized niche markets that address Alzheimer’s disease, traumatic brain injury, depression, epilepsy, ADHD, stroke, sleep disorders, dementia, migraine, and more. It’s estimated that the U.S. medical device industry will grow to $208 billion by 2023, and BRSF is ready to meet that increasing need.
For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://nnw.fm/BRSF
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- 5,900 hospitals in the US lack the necessary extensive EEG tech
- BRSF has created a cost-effective solution capable of supplying these hospitals with the equipment needed and broadening the reach of each neurologist
- Emergency departments and hospitals are not the only markets in need of brain monitoring devices, and the industry is expected to grow to $208 billion by 2023
For most U.S. patients, an EEG is mostly unavailable during their journey, from home by EMS to the Emergency department. Additionally, for those patients who are admitted to the ICU, less than 45 percent of ICUs offer EEG monitoring. There are approximately 6,090 hospitals in the U.S., and around 5,900 of them lack the necessary extensive EEG tech coverage. There are several reasons for the lack of access:
- Costs and/or space: 70% of US hospitals do not have the equipment for routine EEGs
- Traditional EEGs require a specialized technician to administer and read the data
- The equipment is bulky, which restricts accessibility and mobility
- Twenty (20) states have less than 10 neurologists per 10,000 patients
- Neurological care needs are increasing with the aging population
Brain Scientific (OTCQB: BRSF) has created a solution that makes EEG technology accessible. The Company’s neurotech ecosystem is making it possible for all hospitals to perform EEG tests efficiently. The technology is simple to use. Neurologists are given the resources necessary to automate the tedious tasks and focus their energy on the patient while simultaneously broadening their range of impact.
BRSF’s ecosystem begins with the disposable and easy-to-apply clinical-grade NeuroCap(TM), patented and FDA-cleared, that comes in small, medium, large, and pediatric (extra small) sizes. This disposable headset comes equipped with 22 pre-gelled electrodes that eliminate the task of head measurement and electrode placement. This significantly reduces the amount of time needed to set up, limiting the amount of contact between the patient and the medical professional applying the headset. In addition, because it is disposable and does not need to be painstakingly cleaned before moving on to the next patient, more EEGs can be administered, and the risk of cross-infection is significantly reduced.
The NeuroEEG(TM), patented and FDA cleared, is a portable and wireless EEG amplifier that fits into the palm of your hand and is used to monitor electrical brain activity.
By making EEG technology more available, BRSF has created a time-saving and cost-effective solution for hospitals while simultaneously meeting the growing need for additional neurological care of the communities those hospitals serve.
Emergency departments and hospitals are not the only markets that require brain monitoring devices. Improved technology is necessary in specialized niche markets that address Alzheimer’s disease, traumatic brain injury, depression, epilepsy, ADHD, stroke, sleep disorders, dementia, migraine, and more. It’s estimated that the U.S. medical device industry will grow to $208 billion by 2023, and BRSF is ready to meet that increasing need.
For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://nnw.fm/BRSF
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
